Neomorph

About Neomorph

Neomorph is a venture-backed biotechnology company based in San Diego, California, focused on discovering and developing medicines that target undruggable proteins using targeted protein degradation and molecular glue approaches. The team comprises leaders in protein degradation with a track record of scientific discoveries, aiming to advance the science and technology of molecular glue drug discovery and drive a pipeline through clinical development. The company emphasizes a patient-first, science-driven approach and a collaborative work environment while maintaining close ties with research centers in the degradation field. Neomorph seeks to address critical human health problems by expanding the therapeutic potential of protein degradation.